What are the recommendations for antiplatelet therapy in patients undergoing PCI?
The recommendations for antiplatelet therapy in patients undergoing PCI are to use either aspirin combined with a P2Y12 inhibitor (e.g. clopidogrel, prasugrel, or ticagrelor) or an alternative regimen of aspirin and a GP IIb/IIIa inhibitor (e.g. abciximab or tirofiban). It is also recommended to use a loading dose of the P2Y12 inhibitor prior to PCI, followed by long-term maintenance therapy with aspirin and the P2Y12 inhibitor for up to 12 months or longer.